Ads
related to: pfizer stock price- Pricing for Online Trades
No Account Fees or Platform Fees
With Schwab's Trading Services.
- thinkorswim®
Access The Award-Winning Platform
Built By Traders, For Traders.
- Pricing for Online Trades
Search results
Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? - BioNTech (NASDAQ:BNTX)
Benzinga· 4 days agoAlso Read: What’s Going With BioNTech Stock On Monday? The partial hold affects the enrollment of new patients in the trial in the U.S., BioNTech said in an SEC filing.
Sarepta Stock Surges on Expanded Elevidys Approval. It’s a ‘Best-Case’ Scenario for Shares.
Barrons.com· 10 hours agoThe biopharmaceutical company says the drug was approved for ambulatory and non-ambulatory people,...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade |...
The Motley Fool· 6 days agoThe S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark...
Why Wall Street Is Chasing Ozempic Wannabes
The Wall Street Journal· 1 day agoAs Jared Holz, a healthcare equity strategist at ...troubles. Companies such as Bristol-Myers Squibb Pfizer Johnson & Johnson and Merck are all facing...
Sarepta’ stock soars 38% after FDA expands approval for DMD drug
Market Watch· 13 hours agoDuchenne muscular dystrophy is a genetic disease that primarily affects boys and causes muscle...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks· 2 days agoOf these, at present, Eli Lilly appears to be a great stock to have in one’s portfolio based on its strong overall financial performance and robust drug pipeline. Lilly, with ...
FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label
Zacks via Yahoo Finance· 9 hours agoFollowing the label expansion, Sarepta's (SRPT) Elevidys is approved to treat all DMD patients aged four years and older, regardless of ambulation...
3 Underrated Dividend Stock Machines to Turbocharge Your Income
InvestorPlace· 2 days agoOne of them is dividend stocks but you do not want to bet your money on companies that have...
Sarepta Skyrockets After FDA Signs Off On Duchenne Gene Therapy
Investor's Business Daily· 14 hours agoLast year, the FDA granted the Sarepta Therapeutics (SRPT) gene therapy, dubbed Elevidys, an accelerated approval for children ages 4 and 5 with Duchenne muscular dystrophy. Now Thursday night ...
Dividend stocks can help lower your risk. Many are bargains right now.
Morningstar· 7 days agoDuring an interview with MarketWatch, he said that dividend-paying stocks had become especially attractive relative to growth stocks. This chart compares weighted forward price</ ...
